Overview
Motoko Unoki practices in Tokyo, Japan. Unoki is rated as an Elite expert by MediFind in the treatment of ICF Syndrome. Their top areas of expertise are ICF Syndrome, Primary Immunodeficiency (PID), Squamous Cell Lung Carcinoma, and Paraplegia.
Their clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 10 articles in the study of ICF Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- ICF SyndromeUnoki isElite. Learn about ICF Syndrome.
- Distinguished
- Primary Immunodeficiency (PID)Unoki isDistinguished. Learn about Primary Immunodeficiency (PID).
- Experienced
- ParaplegiaUnoki isExperienced. Learn about Paraplegia.
- Squamous Cell Lung CarcinomaUnoki isExperienced. Learn about Squamous Cell Lung Carcinoma.